Zimbabwe has rejected a significant American health deal worth $367m (£272m) over five years because of the United States' request for sensitive biological samples.
The decision was revealed following a internal memorandum from December was leaked, which showed President Emmerson Mnangagwa felt the arrangement was "skewed".
An official representative later explained that the United States was seeking genetic material for scientific study and commercial gain but was not willing to guarantee the resulting advantages from any future treatments.
"We must now begin the challenging and unfortunate task of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had furnished over $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for further talks to secure a deal acceptable to both sides so the nation's vital HIV programme can continue.
Broader Implications
This rejection comes after a comparable case in neighbouring Kenya, where a court blocked a similar health funding agreement following legal challenges were filed about the safety of Kenyans' medical information.
Since returning to office recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
The agency had overseen assistance for the American government, but Trump argued its expenditure was "wasteful" and his government was pursuing government-to-government agreements to boost transparency and accountability.
As per statements, Sixteen African countries have so far signed similar health pacts, constituting over $18.3bn of fresh investment.
Details of the Declined Agreement
The money for Zimbabwe would have supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving antiretroviral therapy through American-funded initiatives," Tremont added.
However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".
"Zimbabwe was being asked to provide its genetic material and health information for a long time, without any equivalent guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that provided information," Mangwana explained.
"Effectively, our nation would provide the raw materials for scientific discovery without any certainty that the final treatments would be accessible to our citizens should a new pandemic arise."
National Interest and International Frameworks
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting structures already set up via the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to manage potential pandemics.
"This mechanism is intended to ensure that when a country contributes its samples, the benefits – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as opposition to America," he added.
"We encourage ongoing dialogue with our US partners on how subsequent collaboration could be structured in a manner that respects the independence and interests of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but recommended that negotiations need to persist given that much of the country's Aids initiatives were funded by external financing.
"If technical issues arise, including those involving information security or agreement terms, these can frequently be addressed via detailed discussion and negotiated safeguards," the group added.
This impasse highlights the ongoing tensions between receiving much-needed foreign assistance and protecting local interests in an ever more interconnected world.